Evidence map›Paper›PMID 39447865›Full record

ArticlePractical radiation oncology

The Radiosurgery Society Working Groups on GRID, LATTICE, Microbeam, and FLASH Radiotherapies: Advancements Symposium and Subsequent Progress Made.

James W Snider, Nina A Mayr, Jason Molitoris, Arpit M Chhabra, Sina Mossahebi, Robert Griffin, Majid Mohiuddin, Hualin Zhang, Beatriz Amendola, Slavisa Tubin and 9 more

Abstract read
In one paragraph

Article in Practical radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

James W SniderProton International, LLC, Alpharetta, Georgia. Electronic address: jsnider@protonintl.com.
Nina A MayrMichigan State University, East Lansing, Michigan.
Jason MolitorisUniversity of Maryland School of Medicine, Department of Radiation Oncology, Baltimore, Maryland.
Arpit M ChhabraNew York Proton Center, New York, New York.
Sina MossahebiUniversity of Maryland School of Medicine, Department of Radiation Oncology, Baltimore, Maryland.
Robert GriffinUniversity of Arkansas for Medical Sciences, Department of Radiation Oncology, Little Rock, Arkansas.
Majid MohiuddinNorthwestern Chicago Proton Center, Warrenville, Illinois.
Hualin ZhangUniversity of Southern California, Department of Radiation Oncology, Los Angeles, California.
Beatriz AmendolaInnovative Cancer Institute, Miami, Florida.
Slavisa TubinMedAustron, Wiener Neustadt, Austria.
Minglei KangNew York Proton Center, New York, New York.
Charles LimoliUniversity of California, Irvine, Department of Radiation Oncology, Irvine, California.
Kimberly MarterUniversity of Maryland Medical Center, Department of Radiation Oncology, Baltimore, Maryland.
Naipy PerezInnovative Cancer Institute, Miami, Florida.
Gwendolyn O RustinProton International, LLC, Alpharetta, Georgia.
Anand MahadevanNew York University, Langone Health, Department of Radiation Oncology, New York, New York.
C Norman ColemanNational Cancer Institute, Bethesda, Maryland.
Mansoor AhmedNational Cancer Institute, Bethesda, Maryland.
Charles B SimoneNew York Proton Center, New York, New York.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

purposeSince the inaugural workshop "Understanding High-Dose, Ultra-High Dose Rate and Spatially Fractionated Radiotherapy." hosted by the National Cancer Institute and sponsored by the Radiosurgery Society (RSS), growing collaborations and investigations have ensued among experts, practitioners, and researchers. The RSS GRID, LATTICE, Microbeam and FLASH (GLMF) Working Groups were formed as a framework for these efforts and have focused on advancing the understanding of the biology, technical/physical parameters, trial design, and clinical practice of these new radiation therapy modalities. METHODS AND MATERIALS: In view of the steadily increasing clinical interest in Spatially Fractionated Radiotherapy (SFRT) and FLASH, a full-day symposium entitled "Advancements in GRID, LATTICE, and FLASH Radiotherapy Symposium" was established in 2022 that immediately preceded the RSS scientific meeting. This well-attended symposium focused on clinical, technical, and physics approaches for SFRT, and closely examining relevant radiobiological underpinnings. Practical clinical trial development was a highlighted discussion. An additional section reviewed proton therapy and other particle-based techniques for the delivery of GRID and LATTICE therapy. A treatment planning and delivery tutorial for GRID, LATTICE, and proton GRID/LATTICE was directed toward the real-world considerations for the development of new clinical GRID or LATTICE programs. An overall similar approach was applied to the discussion of FLASH. This report summarizes the content of the first GLMF Symposium and related work of the RSS GLMF Working Groups in the field of heterogeneous and ultrahigh dose rate irradiation, over approximately 2 years.

resultsThe GLMF Working Groups have continued to expand in membership and attendance, and several resultant trial concepts, research efforts, academic discussions, and peer-reviewed publications have followed as the number of institutions and practitioners using SFRT and FLASH continues to grow.

conclusionsThe GLMF Working Groups and the RSS continue to demonstrate excellent progress in proliferating use of and improving understanding of SFRT and ultrahigh dose rate radiation therapy techniques.

Indexed as

NeoplasmsRadiosurgeryCongresses as TopicDose Fractionation, RadiationHumans

Identifiers

PMID39447865
PMCPMC12128894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.